Major Shareholders

Summary of Issued Securities 

Ordinary Shares

 
Issued shares at 30 September 2023

722,071,160

Employee options over ordinary shares at 12 October 2023

35,115,945

Director options over ordinary shares at 6 October 2023

5,000,000

 

Major Shareholders 
The top 20 shareholders in Pharmaxis Ltd at 30 June 2023 are:

Name

Number Of Shares

'000

% Total 
1. Citicorp Nominees Pty Limited 146,692 20%
2. HSBC Custody Nominees (Australia) Limited  - A/C 2 108,361 15%
3. HSBC Custody Nominees (Australia) Limited 72,665 10%
4. D&A Income Limited 38,690 5%
5. Lawn Views Pty Ltd (Angela Williams Family A/C) 10,351 1%
6. Dr Toby David Cohen 6,749 1%
7. BNP Paribas Nom Pty Ltd (DRP) 6,517 1%
8. Healthcare Management Consulting (Australia) Pty Ltd 5,263 1%
9. Mr David Curzon Smith + Mrs Diane Maurine Smith (Badham Family a/c) 4,256 1%
10. Ms Bei Xu + Mr Donging Wu 3,601 1%
11. Indcorp Consulting Group Pty Limited (Superannuation Fund A/C) 3,000 0%
12. Mr Xing Jiang Xue 2,730 0%
13. Finter Nominees Pty Ltd (TJF Family A/C) 2,700 0%
14. Pakasoluto Pty Limited (Barkl Family Super Fund) 2,622 0%
15. Mr Peter John Carr 2,510 0%
16. BNP Paribas Nominees Pty Ltd ACF Clearstream 2,503 0%
17. Bunyula Super Pty Ltd (Bunyula Family Super Fund A/C) 2,477 0%
18. Joseph Wallace Carson 2,476 0%
19. Mr Gregory Bruce Cole + Mrs Julia Theresa Cole (Greg & Julie Super Fund A/C) 2,430 0%
20. Mrs Sharon Lewis 2,266 0%

Note: the above tables are updated after each quarter end

Substantial Shareholders 

Name Percent Date 
BVF Partners LP 15% 14 December 2022
Karst Peak Capital Limited 12% 11 February 2022
D&A Income Limited 12% 9 August 2023
Platinum Investment Management Limited 8% 6 December 2022

Directors' Interests

Current director's interest notices can be found here: